Search Results

Doxorubicin is a chemotherapy drug used to treat many cancers, but it causes serious heart damage in some patients. Heart muscle cells made from the skin cells of breast cancer patients can be used to study this phenomenon.

The implications of emerging biotechnologies and what they mean for human reproduction and making babies raises legal, ethical and social issues, according to law professor Hank Greely.

People with cancer have tumor DNA in their blood. A new way to quiet background “noise” in the blood sample allows researchers to sequence minute quantities of these molecules to improve diagnosis and treatment.

Researchers have identified a link between the expression of a cancer-related gene and cell-surface molecules that protect tumors from the immune system.

Nearly 30 years after the discovery of the hematopoietic stem cell, Stanford researchers have found a marker that allows them to study the version of these stem cells that continues to replicate.

Stanford’s clinical and translational research center has awarded funding to teams of multidisciplinary investigators who are tackling health-care problems through novel approaches.

Irving Weissman had an unconventional start in science. The son of a hardware store operator and grandson of a fur trader, he learned lifelong lessons in research at the McLaughlin Research Institute in Montana.

Steven Artandi, Linda Boxer, Anne Brunet, Thomas Clandinin, Leonore Herzenberg and Joseph Wu have been appointed to endowed professorships at the School of Medicine.

A small subset of colon cancers lacks the CDX2 protein — a hallmark of colon tissue maturation. Patients with these cancers may benefit more than others from chemotherapy.

Crystal Mackall will lead the university’s efforts to translate basic science discoveries into immune-based treatments for pediatric and adult cancers.